2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
FDA Comment Number : | EC3322 | |||||||||||||||||||||||
Submitter : | Mrs. Marsha O'Flaherty | Date & Time: | 12/15/2006 08:12:31 | |||||||||||||||||||||
Organization : | Mrs. Marsha O'Flaherty | |||||||||||||||||||||||
Category : | Individual Consumer | |||||||||||||||||||||||
Issue Areas/Comments | ||||||||||||||||||||||||
GENERAL | ||||||||||||||||||||||||
GENERAL | ||||||||||||||||||||||||
Please use "ethical" (non-aborted-fetal) methods of line development.
If the medical establishments of Europe can do it, so can the U.S. Or are we so far behind them? I will not use such medications...and will strongly encourage others to also boycott such meds. | ||||||||||||||||||||||||